Kanada - Ingliż - Health Canada

generic medical partners inc - daunorubicin (daunorubicin hydrochloride) - solution - 50mg - daunorubicin (daunorubicin hydrochloride) 50mg - antineoplastic agents

Kanada - Ingliż - Health Canada

hikma canada limited - daunorubicin (daunorubicin hydrochloride) - solution - 20mg - daunorubicin (daunorubicin hydrochloride) 20mg

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

daunorubicin -

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - daunorubicin, quantity: 20 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - indications as at 22 november 2004 : daunorubicin injection is indicated for the treatment of the following: acute lymphocytic (lymphoblastic) leukaemia: daunorubicin is usually reserved for use in cases shown to be resistant to other drugs. however, combined treatment with daunorubicin, vincristine and a steroid has been used in the early stages of this disease. acute myeloblastic leukaemia: daunorubicin has been used in all stages, alone or in combination with other cytotoxic agents (e.g. cytarabine). disseminated solid tumours: daunorubicin has been investigated for use in these tumours and found to be effective in some cases of disseminated neuroblastoma and rhabdomyosarcoma.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - daunorubicin hydrochloride, quantity: 2.14 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - - acute lymphocytic (lymphoblastic) leukaemia. daunorubicin is usually reserved for use in cases shown to be resistant to other drugs. however, combined treatment with daunorubicin, vincristine and a steroid has been used in the early stages of the disease. - acute myeloblastic leukaemia. daunorubicin has been used in all stages, alone or in combination with other cytotoxic agents e.g., cytarabine. - disseminated solid tumours. daunorubicin has been investigated for use in these tumours and found to be effective in some cases of disseminated neuroblastoma and rhabdomyosarcoma.

Malta - Ingliż - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - daunorubicin - powder for injection - daunorubicin 20 mg - antineoplastic agents

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - daunorubicin hydrochloride, quantity: 2.14 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - daunorubicin is an anthracycline, antineoplastic agent used as a standard component of various regimes for the treatment of leukemia. disseminated tumors - daunorubicin has been investigated for use in these tumors and has found to be effective in some cases of disseminated neuroblastoma and rhabdomyosarcoma.

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - daunorubicin hydrochloride - powder for concentrate for solution for infusion - 20 milligram(s) - anthracyclines and related substances; daunorubicin

Panama - Ingliż - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

remedy pharma - daunorubicina (clorhidrato) - daunorubicina (clorhidrato)....20 mg

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

jazz pharmaceuticals anz pty ltd - daunorubicin, quantity: 44 mg; cytarabine, quantity: 100 mg - injection, powder for - excipient ingredients: cholesterol; sucrose; distearoylphosphatidylglycerol; trolamine; copper gluconate; distearoylphosphatidylcholine - vyxeos is indicated for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukaemia (t-aml) or aml with myelodysplasia-related changes (aml-mrc)